AT395922T - Lipid-analogous to the treatment of viral infections - Google Patents

Lipid-analogous to the treatment of viral infections

Info

Publication number
AT395922T
AT395922T AT95928365T AT95928365T AT395922T AT 395922 T AT395922 T AT 395922T AT 95928365 T AT95928365 T AT 95928365T AT 95928365 T AT95928365 T AT 95928365T AT 395922 T AT395922 T AT 395922T
Authority
AT
Austria
Prior art keywords
lipid
analogous
treatment
viral infections
infections
Prior art date
Application number
AT95928365T
Other languages
German (de)
Inventor
Louis S Kucera
Susan L Morris-Natschke
Khalid S Ishaq
Original Assignee
Univ Wake Forest
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29741694A priority Critical
Priority to US31490194A priority
Application filed by Univ Wake Forest, Univ North Carolina filed Critical Univ Wake Forest
Publication of AT395922T publication Critical patent/AT395922T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
AT95928365T 1994-08-29 1995-08-07 Lipid-analogous to the treatment of viral infections AT395922T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US29741694A true 1994-08-29 1994-08-29
US31490194A true 1994-09-29 1994-09-29

Publications (1)

Publication Number Publication Date
AT395922T true AT395922T (en) 2008-06-15

Family

ID=26970138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928365T AT395922T (en) 1994-08-29 1995-08-07 Lipid-analogous to the treatment of viral infections

Country Status (8)

Country Link
US (6) US5962437A (en)
EP (2) EP0781138B1 (en)
JP (3) JP4259611B2 (en)
AT (1) AT395922T (en)
AU (1) AU3216695A (en)
CA (1) CA2197319C (en)
DE (1) DE69535758D1 (en)
WO (1) WO1996006620A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT395922T (en) * 1994-08-29 2008-06-15 Univ Wake Forest Lipid-analogous to the treatment of viral infections
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
DE19855963A1 (en) * 1998-12-04 2000-06-08 Herbert Schott Amphiphilic glyceryl, processes for their preparation and their use
US6670341B1 (en) * 1999-10-28 2003-12-30 Wake Forest University Health Sciences Compositions and methods for double-targeting virus infections and targeting cancer cells
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) * 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
US8071740B2 (en) * 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
JP2004537580A (en) * 2001-08-10 2004-12-16 エピックス メディカル, インコーポレイテッド Polypeptide conjugates with prolonged circulating half-life
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
EP1423976A1 (en) 2001-08-31 2004-06-02 Thomson Licensing S.A. Sequence counter for an audio visual stream
WO2003033514A1 (en) 2001-10-19 2003-04-24 Vascular Biogenics Ltd. Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
WO2005075398A1 (en) * 2004-02-04 2005-08-18 Jsr Corporation Calixarene compound, process for producing the same, intermediate therefor, and composition thereof
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
HUE032657T2 (en) 2004-03-29 2017-10-30 Univ South Florida Effective treatment of tumors and cancer with triciribine phosphate
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
US7807847B2 (en) 2004-07-09 2010-10-05 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
EP1865967A4 (en) * 2005-04-08 2011-02-09 Chimerix Inc Compounds, compositions and methods for the treatment of viral infections and other medical disorders
JP2008535862A (en) * 2005-04-08 2008-09-04 キメリクス,インコーポレイテッド Compounds for the treatment of poxvirus infections, the compositions and methods
US7749983B2 (en) 2006-05-03 2010-07-06 Chimerix, Inc. Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
EP2070938A1 (en) 2007-12-13 2009-06-17 Heidelberg Pharma AG Clofarabine dietherphospholipid derivatives
EP3085377A1 (en) * 2008-01-25 2016-10-26 Chimerix, Inc. Methods of treating viral infections
CN104788492A (en) * 2008-11-06 2015-07-22 脉管生物生长有限公司 Oxidized lipid compounds and uses thereof
US8614200B2 (en) 2009-07-21 2013-12-24 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
US9006218B2 (en) 2010-02-12 2015-04-14 Chimerix Inc. Nucleoside phosphonate salts
CA2797601A1 (en) 2010-04-26 2011-11-10 Chimerix, Inc. Methods of treating retroviral infections and related dosage regimes
US20140323392A1 (en) * 2011-03-28 2014-10-30 University Of Utah Research Foundation Methods and compositions related to inhibition of viral entry
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
WO2016084023A1 (en) 2014-11-26 2016-06-02 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2108765A (en) * 1938-02-15 Preserving and disinfecting media
US2086585A (en) * 1933-04-13 1937-07-13 Alba Pharmaceutical Company In Quaternary ammonium compounds
US2087132A (en) * 1933-04-13 1937-07-13 Alba Pharmaceutical Company In Quaternary ammonium compounds
US2209383A (en) * 1938-03-05 1940-07-30 Rohm & Haas Process of waterproofing fabrics
US2445393A (en) * 1944-03-08 1948-07-20 Rhone Poulenc Sa New amino-derivatives of dioxa-cyclopentane
US2439969A (en) * 1944-04-17 1948-04-20 Rhone Poulenc Sa Amino-dioxacyclopentanes
US2513747A (en) * 1945-10-04 1950-07-04 Ciba Ltd Cyclic amino-acetals
US2606909A (en) * 1947-08-01 1952-08-12 Univ Michigan Basic dioxolanes
US2689790A (en) * 1951-09-26 1954-09-21 Monsanto Chemicals Nitrogenous compound herbicides
DE1050298B (en) * 1953-07-29
US3054678A (en) * 1958-04-16 1962-09-18 Michener Harold David Preservation process with quaternary ammonium compounds
DE1619043B2 (en) * 1967-04-07 1977-11-03 Means for softening of textiles and simultaneously convey a good absorbency
US4119714A (en) * 1970-02-27 1978-10-10 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E. V. Glycerin-alkylether-(1)-phosphoric acid-(3)-monocholine esters as enhancers of the natural resistance of the mammalian organism against non-carcinogenic pathogens
DE2033359C3 (en) * 1970-07-06 1980-02-14 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen
JPS49100224A (en) * 1973-01-29 1974-09-21
US4093714A (en) * 1974-03-15 1978-06-06 Icn Pharmaceuticals, Inc. 9β-D-Arabinofuranosylpurine nucleotides and method of use
US4159988A (en) * 1974-08-06 1979-07-03 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Synthetic phospholipids, a process for their manufacture and their use
FR2356425B1 (en) * 1976-07-01 1978-12-15 Roussel Uclaf
US4291024A (en) 1978-04-10 1981-09-22 Turcotte Joseph G Cytotoxic liponucleotide analogs
DE2820893C2 (en) 1978-05-12 1986-02-20 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4235877A (en) * 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4329302A (en) * 1980-06-27 1982-05-11 Board Of Regents, The University Of Texas System Synthetic phosphoglycerides possessing platelet activating properties
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
DE3039629A1 (en) * 1980-10-21 1982-06-03 Boehringer Mannheim Gmbh Alkanol phosphoric acid mono-ammonium alkyl ester(s) - are cancerostatic phospholipid(s) which do not cause thrombocyte aggregation
JPS5772914A (en) * 1980-10-22 1982-05-07 Motoo Hozumi Antitumor agent
US4471113A (en) * 1982-02-03 1984-09-11 The United States Of America As Represented By The Department Of Energy Prodrugs based on phospholipid-nucleoside conjugates
EP0094586A3 (en) * 1982-05-13 1984-06-06 Ono Pharmaceutical Co., Ltd. Glycerol derivatives, process for preparing same and pharmaceutical composition containing same
US4661509A (en) * 1982-09-28 1987-04-28 Gordon Arnold Z Methods for treating leukopenia
JPS5988447A (en) * 1982-11-11 1984-05-22 Ono Pharmaceut Co Ltd Glycerol derivative, its production and agent containing said derivative
FR2540122B1 (en) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Novel compounds having an oligonucleotide sequence bound to an intercalating agent, their process of synthesis and their application
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (en) 1983-08-30 1985-04-24 Oreal Cosmetic or pharmaceutical composition in aqueous or anhydrous form in which the fat phase contains a polyether oligomer and polyether oligomers new
JPH0372077B2 (en) * 1983-10-11 1991-11-15 Takeda Yakuhin Kogyo Kk
JPS60100544A (en) * 1983-11-08 1985-06-04 Ono Pharmaceut Co Ltd Novel glycerin derivative, its preparation and drug containing it
JPH0564139B2 (en) * 1983-11-10 1993-09-14 Ono Pharmaceutical Co
JPS60105650A (en) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd Glycerol derivative, production thereof and pharmaceutical containing said derivative
US4540521A (en) * 1984-01-16 1985-09-10 National Distillers And Chemical Corporation Liquid quaternary ammonium antistatic compositions
US4622392A (en) 1984-06-21 1986-11-11 Health Research Inc. (Roswell Park Division) Thiophospholipid conjugates of antitumor agents
JPS6124519A (en) * 1984-07-11 1986-02-03 Shoshichi Nojima Antitumor agent
US4826823A (en) * 1985-02-05 1989-05-02 Warner-Lambert Company Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
IT1188654B (en) 1985-04-15 1988-01-20 Toyo Jozo Kk Conjugate side-phospholipid core
JPS61238793A (en) 1985-04-17 1986-10-24 Toyo Jozo Co Ltd Novel phospholipid derivative
US4619917A (en) * 1985-07-18 1986-10-28 Sandoz Pharm. Corp. Substituted 2-furanyl- or 5-oxo-2-furanyl methoxy phosphoryl alkyl cyclimmonium salts
CA1338627C (en) * 1985-12-04 1996-10-01 Hansjorg Eibl Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
US4841039A (en) * 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
DE3619748A1 (en) * 1986-06-12 1987-12-17 Merz & Co Gmbh & Co antimicrobial agent
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
DE3778626D1 (en) 1986-09-27 1992-06-04 Toyo Jozo Kk Nucleoside-phospholipid conjugate.
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
JPS6429319A (en) * 1987-07-23 1989-01-31 Toyama Chemical Co Ltd Antiviral agent containing lysolecithin and phospholipid
DE3726945A1 (en) * 1987-08-13 1989-02-23 Dietl Hans L-Carnitine derivatives of valproic acid and pharmaceuticals containing these
US4894389A (en) * 1987-10-02 1990-01-16 Merrell Dow Pharmaceuticals Inc. Novel aminoalkyl-substituted heterocyclic sulfur compounds
US4997761A (en) 1987-10-06 1991-03-05 Houston Biotechnology Incorporated Phosphatidyl treatment of viral disease
EP0335396A1 (en) * 1988-04-01 1989-10-04 MAGIS FARMACEUTICI S.p.A. Glycero-phosphoric and -diphosphoric acids derivatives of L-carnitine or L-carnitine esters
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
JPH01293129A (en) 1988-05-20 1989-11-27 Kobe Steel Ltd Continuous high temperature and high pressure treatment device
FI106461B (en) * 1989-12-22 2001-02-15 Wellcome Found Process for the preparation of enantiomeric compounds useful therapeutically, as well as a method useful intermediate
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
EP0348859A1 (en) * 1988-07-01 1990-01-03 MAGIS FARMACEUTICI S.p.A. 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
CA2001401A1 (en) 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
GB8827337D0 (en) * 1988-11-23 1988-12-29 Medical Res Council Nucleoside analogues
US5221696A (en) 1989-03-29 1993-06-22 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
FI902821A0 (en) * 1989-06-12 1990-06-06 Res Found Mental Hygiene Foerminskning infektionsspridning by means of blodbehandlingsapparatur.
DE3929217A1 (en) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Use of phospholipid derivatives as antiviral drug and new phospholipids
DE3934820A1 (en) * 1989-10-19 1991-04-25 Boehringer Mannheim Gmbh Using lecithin analogues as derivatives and new antiviral drug
GB2239243B (en) 1989-12-22 1993-05-12 Scras Glycerol derivatives
GR1000688B (en) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Glycerine derivatives preparation method
DE3942933A1 (en) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Using alkylphospholipiden as antiviral drug and new phospholipid derivatives
US5026687A (en) 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
DE4010228A1 (en) * 1990-03-30 1991-10-02 Werner E G Prof Dr Mueller Prepn. of antiviral, esp. anti-AIDS agent - by mixing halo-contg. higher alkyl-glycerol-phospho-choline analogues with suitable carrier
JPH05507279A (en) * 1990-05-29 1993-10-21
EP0533825B1 (en) * 1990-06-15 1996-04-24 Wake Forest University Ether lipid-nucleoside covalent conjugates
US5138045A (en) * 1990-07-27 1992-08-11 Isis Pharmaceuticals Polyamine conjugated oligonucleotides
DE4026265A1 (en) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drug
WO1992004887A1 (en) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Induction of cytotoxic t cell
WO1992006192A1 (en) * 1990-10-09 1992-04-16 Vestar, Inc. Inhibition of viral replication
EP0594677A4 (en) 1991-07-12 1997-09-17 Vical Inc Antiviral liponucleosides: treatment of hepatitis b
AU662367B2 (en) * 1991-10-28 1995-08-31 Mona Industries, Inc. Phospholipid antimicrobial compositions
DE4204032A1 (en) * 1992-02-12 1993-08-19 Boehringer Mannheim Gmbh New liponucleotide whose herstellunmg and their use as antiviral drug
DE4204031A1 (en) * 1992-02-12 1993-08-19 Boehringer Mannheim Gmbh New lipidphosphonsaeure-nucleoside conjugate and their use as antiviral drug
GB9204015D0 (en) * 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
US6602861B1 (en) * 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
US5512671A (en) 1993-02-16 1996-04-30 Wake Forest University Ether lipid-nucleoside covalent conjugates
WO1994019012A2 (en) 1993-02-24 1994-09-01 Wang Jui H Compositions and methods of application of reactive antiviral polymers
IL105244A (en) 1993-03-31 2003-07-31 Dpharm Ltd Prodrugs with enhanced penetration into cells
CA2164717C (en) 1993-06-10 2009-10-20 Louis S. Kucera Method of combatting hepatitis b virus infection
DE69426904D1 (en) * 1993-06-29 2001-04-26 Mitsubishi Chem Corp Phosphonate-nucleotide ester derivatives
KR967003604A (en) 1993-07-19 1996-08-31 아사이 이페이 Hepatitis C virus proliferation inhibitor (Hepatitis C Virus Proliferation Inhibitor)
AT395922T (en) 1994-08-29 2008-06-15 Univ Wake Forest Lipid-analogous to the treatment of viral infections
JP3786447B2 (en) 1995-03-31 2006-06-14 エーザイ株式会社 An agent for the prophylaxis or treatment of hepatitis C
US6413949B1 (en) 1995-06-07 2002-07-02 D-Pharm, Ltd. Prodrugs with enhanced penetration into cells
US5830905A (en) 1996-03-29 1998-11-03 Viropharma Incorporated Compounds, compositions and methods for treatment of hepatitis C
US5633388A (en) 1996-03-29 1997-05-27 Viropharma Incorporated Compounds, compositions and methods for treatment of hepatitis C
US5891874A (en) 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
JP3927630B2 (en) 1996-09-27 2007-06-13 エーザイ・アール・アンド・ディー・マネジメント株式会社 A viral infection of the preventive or therapeutic agent
US5922757A (en) 1996-09-30 1999-07-13 The Regents Of The University Of California Treatment and prevention of hepatic disorders
JPH10293129A (en) 1997-04-18 1998-11-04 Nof Corp Method for measuring endotoxin in phospholipid
PL193237B1 (en) 1997-06-30 2007-01-31 Merz Pharma Gmbh & Co. Kgaa Derivatives of 1-aminoalkyl cyclohexane as antagonists of nmda receptor
GB9806815D0 (en) 1998-03-30 1998-05-27 Hoffmann La Roche Amino acid derivatives
US6670341B1 (en) 1999-10-28 2003-12-30 Wake Forest University Health Sciences Compositions and methods for double-targeting virus infections and targeting cancer cells
EP1241432B1 (en) 2001-03-15 2006-08-23 Teijin Twaron GmbH Penetration-resistant material comprising fabric with high linear density ratio of two sets of threads

Also Published As

Publication number Publication date
EP0781138A2 (en) 1997-07-02
US5962437A (en) 1999-10-05
US7294621B2 (en) 2007-11-13
US7294620B2 (en) 2007-11-13
US20070105812A1 (en) 2007-05-10
JP4259611B2 (en) 2009-04-30
US20070099870A1 (en) 2007-05-03
US7129227B1 (en) 2006-10-31
US20050080050A1 (en) 2005-04-14
WO1996006620A3 (en) 1996-06-13
US8106032B2 (en) 2012-01-31
WO1996006620A2 (en) 1996-03-07
CA2197319A1 (en) 1996-03-07
CA2197319C (en) 2009-01-27
EP0781138B1 (en) 2008-05-21
JP2011051996A (en) 2011-03-17
DE69535758D1 (en) 2008-07-03
JPH10506619A (en) 1998-06-30
EP1852121A3 (en) 2007-11-21
EP1852121A2 (en) 2007-11-07
JP2007056033A (en) 2007-03-08
US20080293667A1 (en) 2008-11-27
AU3216695A (en) 1996-03-22
US7141557B2 (en) 2006-11-28

Similar Documents

Publication Publication Date Title
DE69530192D1 (en) L-nucleosides for the treatment of hepatitis B and Epstein Bar virus
DE69534995D1 (en) Variants of antigenic human papillomavirus
DE69230772D1 (en) Pharmaceutical preparations for the treatment of onychomycosis
DE69535307D1 (en) Guanylhydrazone to treat inflammation
DE3786558D1 (en) Composition for the treatment of obesity.
DE69225470T2 (en) Treatment of waste
DE69832022D1 (en) System for the treatment of neurological diseases
DE69625906D1 (en) Dinucleotides for use in the treatment of lung diseases
DE122006000014I2 (en) Pyranone for treating retroviral infections
DE69523080T2 (en) Knee brace for the treatment of osteoarthritis
DE69932984D1 (en) System and treatment for the suppression of Sepsis
DE69431056D1 (en) Oxazolyl substituted derivatives for the treatment of inflammation
DE19875011I2 (en) Use of sertindole for the treatment of Shiz ophrenie.
DE69831567D1 (en) Device for treatment of herzarrhythien
DE69830592D1 (en) System for treatment of lymphedema
DE69529173D1 (en) Heterocyclic bizykeln for treatment of impotence
DE3889964T2 (en) Method and composition for the treatment and prevention of viral infections.
AT529102T (en) Connection to the prevention and treatment of glaucoma
DE3684363D1 (en) Phosphonylmethoxyalkyl-adenines for treatment of viral diseases.
DE69737793D1 (en) Benzimidazole-2-carbamate for treatment of viral infections and cancer
DE3751470D1 (en) Pentigetide for the treatment of non-IgE-mediated inflammatory diseases.
AT168007T (en) For treatment of diseases of the central nervous system usable benzimidazole
DE69115990T2 (en) Composition for the treatment of dry eye disease
DE69527955D1 (en) Treatment of glucans with enzymes
DE69736249D1 (en) Treatment of pain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties